- Advertisement -

Could a flavonoid found in common fruit and vegetables combat COVID-19?

Researchers in India have gathered and presented a large body of evidence highlight quercetin – a flavonoid molecule found in many common fruits and...

Azerbaijan Thalassemia Center and BGI partner to improve thalassemia screening in Azerbaijan

On 6th September 2022, the Azerbaijan Thalassemia Center and BGI held a virtual signing ceremony to seal a Collaboration Agreement. The partnership aims to...

Nuclera expands access to eProtein Discovery for APAC customers with distributor agreement in Australia and New Zealand

Nuclera, the biotechnology company accelerating drug discovery by providing rapid, easy access to functional proteins through its benchtop eProtein Discovery™ System, today announced that...

Study links prior authorization to delayed heart failure prescriptions

Prior authorization, a process that requires physicians to obtain approval from health care insurers before certain treatments are covered, may keep patients from filling...

Synergistic Impact of Dual-Targeted Therapies with Chemotherapy Achieves Promising Response Rates...

In recent advancements in the treatment of metastatic colorectal cancer (mCRC) characterized by BRAF V600E mutations, researchers have announced compelling results from the Phase...

New computational method improves analysis of single-cell transcriptomic data

Researchers at Memorial Sloan Kettering Cancer Center (MSK) have developed a new open-source computational method, dubbed Spectra, which improves the analysis of single-cell transcriptomic...

StockWatch: Novartis Loses More than Market Value After Phase III Failure

Novartis (SIX Swiss: NOVN and NYSE: NVS) lost more than just the roughly $30 billion in market capitalization (share price times the number of...

Manus and UT Austin Advance Biomanufacturing Product Recovery Through BioMADE Program

Manus, The BioAlternatives Company®, and the University of Texas at Austin say they have completed a BioMADE-sponsored program to make industrial yeast fermentation more...

StockWatch: Novartis Loses More than Market Value After Phase III Failure

Novartis (SIX Swiss: NOVN and NYSE: NVS) lost more than just the roughly $30 billion in market capitalization (share price times the number of...

Manus and UT Austin Advance Biomanufacturing Product Recovery Through BioMADE Program

Manus, The BioAlternatives Company®, and the University of Texas at Austin say they have completed a BioMADE-sponsored program to make industrial yeast fermentation more...

Data Integrity as the Foundation for AI

Artificial intelligence is advancing quickly into laboratory operations, which is why thinking about the quality and integrity of the supporting data early on is...

more new items

StockWatch: Novartis Loses More than Market Value After Phase III Failure

Novartis (SIX Swiss: NOVN and NYSE: NVS) lost more than just the roughly $30 billion in market capitalization (share price times the number of...

Manus and UT Austin Advance Biomanufacturing Product Recovery Through BioMADE Program

Manus, The BioAlternatives Company®, and the University of Texas at Austin say they have completed a BioMADE-sponsored program to make industrial yeast fermentation more...

Data Integrity as the Foundation for AI

Artificial intelligence is advancing quickly into laboratory operations, which is why thinking about the quality and integrity of the supporting data early on is...